Siri Carpenter is an award-winning science writer and editor based in Madison, Wisconsin. Her work has appeared in The New York Times, The Los Angeles Times, The Washington Post, O: the Oprah Magazine, Science, Scientific American Mind, Science News, and many other publications. She’s first author on the psychology textbook Visualizing Psychology (John Wiley & Sons, 2007). She is also co-founder and editor-in-chief of The Open Notebook, a nonprofit organization and website that provides resources to help science journalists improve their skills.
Siri Carpenter
Freelance Writer
Spectrum
From this contributor
The children who leave autism behind
Some children shed the symptoms of autism and eventually lose their diagnosis. What sets them apart?
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”